The role of anti-IL-5Rα treatment with benralizumab in severe asthma

Autor:	Yu.Yu. Khizhnyak Khizhnyak, S.A. Danilenko Danilenko, M.F. Kinyaykin Kinyaykin, I.V. Naumova Naumova, City Outpatient Clinic № , Yuzhno-Sakhalinsk, Russia
Rok vydání:	2020
Předmět:	chemistry.chemical_compound chemistry business.industry Severe asthma Immunology Medicine Benralizumab business
Zdroj:	Pharmateca. :58-64
ISSN:	2414-9128
DOI:	10.18565/pharmateca.2020.5.58-64
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::aa055b2a88db2d2642c3a2947be9ad0a https://doi.org/10.18565/pharmateca.2020.5.58-64 Zobrazit plný text záznamu